Free Trial

Covea Finance Boosts Holdings in Nutrien Ltd. (NYSE:NTR)

Nutrien logo with Basic Materials background

Covea Finance lifted its stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 21.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 55,600 shares of the company's stock after purchasing an additional 10,000 shares during the period. Covea Finance's holdings in Nutrien were worth $2,485,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of NTR. Silchester International Investors LLP boosted its holdings in Nutrien by 164.4% in the 3rd quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company's stock worth $513,437,000 after buying an additional 6,642,075 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Nutrien in the third quarter valued at approximately $150,181,000. Bank of Montreal Can boosted its stake in shares of Nutrien by 15.5% in the second quarter. Bank of Montreal Can now owns 13,354,385 shares of the company's stock worth $719,668,000 after acquiring an additional 1,794,333 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd increased its position in shares of Nutrien by 78.8% during the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company's stock worth $121,271,000 after purchasing an additional 1,100,000 shares in the last quarter. Finally, Public Sector Pension Investment Board acquired a new position in Nutrien in the 2nd quarter valued at $38,176,000. Institutional investors and hedge funds own 63.10% of the company's stock.

Nutrien Trading Up 0.8 %

Shares of NTR traded up $0.39 during trading on Wednesday, reaching $52.08. 2,280,037 shares of the company traded hands, compared to its average volume of 2,516,826. The stock has a 50-day simple moving average of $46.90 and a 200-day simple moving average of $47.85. The stock has a market cap of $25.64 billion, a PE ratio of 34.95, a price-to-earnings-growth ratio of 1.73 and a beta of 0.81. Nutrien Ltd. has a twelve month low of $43.69 and a twelve month high of $60.87. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38.

Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing analysts' consensus estimates of $0.43 by ($0.04). The company had revenue of $5.35 billion for the quarter, compared to analysts' expectations of $5.26 billion. Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business's revenue for the quarter was down 5.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.35 EPS. On average, analysts anticipate that Nutrien Ltd. will post 3.5 earnings per share for the current year.

Nutrien Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st will be paid a $0.939 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This is a boost from Nutrien's previous quarterly dividend of $0.54. This represents a $3.76 dividend on an annualized basis and a dividend yield of 7.21%. Nutrien's payout ratio is presently 144.97%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. UBS Group cut shares of Nutrien from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $66.00 to $51.00 in a research note on Thursday, October 10th. CIBC restated an "outperformer" rating and set a $55.00 price target (down from $60.00) on shares of Nutrien in a research report on Tuesday, December 10th. Oppenheimer began coverage on shares of Nutrien in a report on Thursday, December 12th. They issued an "outperform" rating and a $60.00 price objective for the company. TD Securities lowered their target price on Nutrien from $63.00 to $61.00 and set a "buy" rating on the stock in a report on Tuesday, November 12th. Finally, Piper Sandler raised Nutrien from an "underweight" rating to an "overweight" rating and increased their price target for the company from $50.00 to $58.00 in a report on Monday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $59.21.

View Our Latest Stock Report on NTR

Nutrien Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Recommended Stories

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines